Low levels of the key B cell activation marker, HLA-DR, in COVID-19 hospitalized cases are associated with disease severity, dexamethasone treatment, and circulating IL-6 levels.

ABSTRACT:

SUBMITTER: Dobi A 

PROVIDER: S-EPMC9178219 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature